Medicare Enrolled

Dr. Ramachandra Rahul Chemitiganti, MD

Endocrinology · Odessa, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
701 W 5TH ST, Odessa, TX 79763
4323351777
In practice since 2006 (19 years)
NPI: 1689610164 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chemitiganti from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chemitiganti? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chemitiganti

Dr. Ramachandra Rahul Chemitiganti is an endocrinology specialist in Odessa, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Chemitiganti performed 180 Medicare services across 123 unique beneficiaries.

Between the years covered by Open Payments, Dr. Chemitiganti received a total of $3,957 from 32 pharmaceutical and/or device companies across 190 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chemitiganti is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 180 Medicare services $3,957 industry payments

Medicare Practice Summary

Medicare Utilization ↗
180
Medicare services
Bottom 17% in TX for endocrinology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
123
Unique beneficiaries
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~9 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity 58 $59 $130
Office visit, established patient (30-39 min) 43 $83 $195
Hemoglobin A1c test (diabetes monitoring) 41 $10 $25
Office visit, established patient (20-29 min) 26 $59 $130
Initial hospital admission, moderate complexity 12 $98 $245
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,957
Total received (2018-2024)
Avg $565/year across 7 years
Top 48% in TX for endocrinology
32
Companies
190
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,957 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$440
2023
$689
2022
$667
2021
$601
2020
$583
2019
$888
2018
$87

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$720
Lilly USA, LLC
$473
AstraZeneca Pharmaceuticals LP
$391
Abbott Laboratories
$345
Amgen Inc.
$203
Horizon Therapeutics plc
$201
Boehringer Ingelheim Pharmaceuticals, Inc.
$192
SANOFI-AVENTIS U.S. LLC
$172
Amryt Pharma Holdings Ltd
$141
Ultragenyx Pharmaceutical Inc.
$123
Corcept Therapeutics
$120
Tandem Diabetes Care, Inc.
$109
Shire North American Group Inc
$107
Radius Health, Inc.
$87
PORTOLA PHARMACEUTICALS, INC.
$73
Insulet Corporation
$56
Dexcom, Inc.
$55
PFIZER INC.
$52
Xeris Pharmaceuticals, Inc.
$40
Medtronic, Inc.
$37
Alexion Pharmaceuticals, Inc.
$37
Takeda Pharmaceuticals U.S.A., Inc.
$36
Medtronic MiniMed, Inc.
$30
SANOFI PASTEUR INC.
$23
Echosens North America, Inc.
$22
DEXCOM, INC.
$19
Bayer Healthcare Pharmaceuticals Inc.
$17
Boston Scientific Corporation
$17
BETA BIONICS, INC.
$16
Esperion Therapeutics, Inc.
$16
Chiesi USA, Inc.
$15
Currax Pharmaceuticals LLC
$13
Top 3 companies account for 40.0% of total payments
Associated products mentioned in payments ›
ANDEXXA · BAQSIMI · CONTRAVE · Crysvita · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DIABETES - DISEASE · Dexcom G6 Transmitter · EVENITY · FARXIGA · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FibroScan · GATTEX · GVOKE PFS · HUMULIN · JARDIANCE · Kerendia · Korlym · LOKELMA · LYUMJEV · MINIMED 780G · MOUNJARO · MYCAPSSA · Macrilen · Minimed 530G · NATPARA (PARATHYROID HORMONE) · NEXLETOL · OCTRODE · Omnipod · Ozempic · PREVNAR 20 · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · SYNJARDY · TEPEZZA · TOUJEO · TRULICITY · Tresiba · Tymlos · VYNDAQEL · Victoza · WATCHMAN FLX · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $2,198 per 100 Medicare services performed
Looking for an endocrinology specialist in Odessa?
Compare endocrinologists in the Odessa area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
6
Per 100K population
3.7
County median income
$71,031
Nearest hospital
MEDICAL CENTER HOSPITAL
6.9 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Chemitiganti is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Chemitiganti experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Chemitiganti performed 58 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chemitiganti receive payments from pharmaceutical companies?
Yes. Dr. Chemitiganti received a total of $3,957 from 32 companies across 190 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chemitiganti's costs compare to other endocrinologists in Odessa?
Dr. Chemitiganti's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chemitiganti) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Odessa
Browse endocrinologists in Odessa ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in TX
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in TX
Which TX endocrinologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →